These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2393768)

  • 21. A retrospective comparison between preoperative and postoperative Breslow depth in primary cutaneous melanoma: how preoperative shave biopsies affect surgical management.
    Saco M; Thigpen J
    J Drugs Dermatol; 2014 May; 13(5):531-6. PubMed ID: 24809875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
    Molenkamp BG; Statius Muller MG; Vuylsteke RJ; van der Sijp JR; Meijier S; van Leeuwen PA
    Eur J Surg Oncol; 2005 Mar; 31(2):211-2. PubMed ID: 15698742
    [No Abstract]   [Full Text] [Related]  

  • 23. Primary cutaneous melanoma with regression does not require a lower threshold for sentinel lymph node biopsy.
    Morris KT; Busam KJ; Bero S; Patel A; Brady MS
    Ann Surg Oncol; 2008 Jan; 15(1):316-22. PubMed ID: 18004626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors associated with local and in-transit recurrence of cutaneous melanoma.
    Stucky CC; Gray RJ; Dueck AC; Wasif N; Laman SD; Sekulic A; Pockaj BA
    Am J Surg; 2010 Dec; 200(6):770-4; discussion 774-5. PubMed ID: 21146019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical considerations in melanoma: staging, excision, and prognostic factors.
    Seyfer AE; Seab JA
    Mil Med; 1981 Nov; 146(11):785-7. PubMed ID: 6798501
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of resection margin on prognosis in clinical stage I malignant melanoma of the lower leg.
    Elberg JJ; Poulsen H; Ladefoged C
    Scand J Plast Reconstr Surg Hand Surg; 1989; 23(1):59-63. PubMed ID: 2740849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Residual melanoma after an excisional biopsy is an independent prognostic factor for local recurrence and overall survival.
    Hocevar M; Dragonja Z; Pilko G; Gazic B; Zgajnar J
    Eur J Surg Oncol; 2014 Oct; 40(10):1271-5. PubMed ID: 24656456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Malignant melanoma: primary surgical management (excision and node dissection) based upon pathology and staging.
    Evans RA
    Cancer; 1995 Dec; 76(11):2384-5. PubMed ID: 8635048
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
    Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.
    Mills JK; White I; Diggs B; Fortino J; Vetto JT
    Am J Surg; 2013 May; 205(5):585-90; discussion 590. PubMed ID: 23592167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous melanoma of the head and neck.
    Loree TR; Spiro RH
    Am J Surg; 1989 Oct; 158(4):388-91. PubMed ID: 2802047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of selective lymph node biopsy for cutaneous malignant melanoma.
    Loggie BW; Hosseinian AA; Watson NE
    Am Surg; 1997 Dec; 63(12):1051-7; discussion 1057-8. PubMed ID: 9393252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Excision of primary melanoma should allow primary closure of the wound.
    Cascinelli N; Santinami M
    Recent Results Cancer Res; 1995; 139():317-21. PubMed ID: 7597300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcopenia as a prognostic factor among patients with stage III melanoma.
    Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
    Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Initial management of cutaneous malignant melanoma.
    Bharwani N
    CMAJ; 1986 Jul; 135(2):128-9. PubMed ID: 3719498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.
    Bolshinsky V; Lin MJ; Serpell J; Leung M; Wolfe R; McLean C; Kelly JW
    J Am Acad Dermatol; 2016 Jan; 74(1):102-7. PubMed ID: 26601566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical management of stage I malignant melanoma.
    Rogers GS
    Dermatol Clin; 1991 Oct; 9(4):649-55. PubMed ID: 1934640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of early recurrence after sentinel lymph node biopsy for melanoma.
    Chao C; Wong SL; Ross MI; Reintgen DS; Noyes RD; Cerrito PB; Edwards MJ; McMasters KM;
    Am J Surg; 2002 Dec; 184(6):520-4; discussion 525. PubMed ID: 12488154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of the primary lesion of malignant melanoma as a guide to prognosis and therapy.
    Kapelanski DP; Block GE; Kaufman M
    Ann Surg; 1979 Feb; 189(2):225-35. PubMed ID: 426555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.